Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    • News

  • Recce Pharmaceuticals Accelerates Commercialisation with Strong Phase II Trial Results
    • News

    Recce Pharmaceuticals Accelerates Commercialisation with Strong Phase II Trial Results

    USD 26 Billion Market Opportunity The global market for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) is expected to grow from USD 7.3 billion in 2018 to USD 26 billion by 2032, highlighting an urgent need for effective new treatments. With the rise of antimicrobial resistance (AMR), demand for novel broad-spectrum antibiotics is at

    Read More
    Public
  • Infomedia Seizes AI Opportunity with 50% Stake in Intellegam
    • News

    Infomedia Seizes AI Opportunity with 50% Stake in Intellegam

    A Strategic Move into AI-Driven Automotive Solutions The automotive industry is at a turning point, driven by the rise of connected cars, changing customer expectations, and a need for efficiency. As businesses scramble for smarter solutions, Infomedia Ltd (ASX:IFM) has made a bold move—securing a 50% stake in European AI startup Intellegam GmbH for €6.1

    Read More
    Public
  • Imugene Advances Cancer Fight with 57% Complete Response Rate in CAR-T Trial
    • News

    Imugene Advances Cancer Fight with 57% Complete Response Rate in CAR-T Trial

    Industry Opportunity: Addressing a Critical Unmet Need The fight against blood cancer is evolving, and Imugene Limited (ASX:IMU) is at the forefront of this battle. With a new wave of promising results from its Phase 1b trial, Imugene’s allogeneic off-the-shelf CD19 CAR-T therapy, azer-cel, is demonstrating significant potential for patients with relapsed/refractory diffuse large B-cell

    Read More
    Public
  • MTM Unlocks Breakthrough in Gallium and Germanium Recovery
    • News

    MTM Unlocks Breakthrough in Gallium and Germanium Recovery

    A Game-Changer for Critical Metals Supply The global semiconductor and defence industries are facing a critical supply chain challenge, with key materials like gallium (Ga) and germanium (Ge) largely controlled by Chinese exports. MTM Critical Metals (ASX:MTM) has taken a major step towards addressing this issue, achieving high recovery rates of these metals from semiconductor

    Read More
    Public
  • Vinyl Group Expands Media Footprint with Launch of Vinyl Media
    • News

    Vinyl Group Expands Media Footprint with Launch of Vinyl Media

    Vinyl Group seizes cultural opportunity with premium publishing expansion Vinyl Group (ASX:VNL) is making bold moves in the Australian media landscape, unveiling a major rebrand and restructure of its media division as Vinyl Media. The company, Australia’s only ASX-listed music entity, is positioning itself as a powerhouse for cultural storytelling, blending premium publishing with audience

    Read More
    Public
  • Memphasys Reaches Key Milestone in Felix™ Clinical Trial, Data Lock Expected Soon
    • News

    Memphasys Reaches Key Milestone in Felix™ Clinical Trial, Data Lock Expected Soon

    Advanced Sperm Selection Technology Moves Closer to Market Memphasys Limited (ASX:MEM) has hit a critical milestone in its pivotal clinical trial for the Felix™ System, an innovative sperm selection technology designed for Assisted Reproductive Technology (ART) procedures. With the Last Patient Last Visit (LPLV) now completed, the company is entering the final phase before results

    Read More
    Public
  • Radiopharm’s RAD 101 Shows Promise in Detecting Brain Metastases
    • News

    Radiopharm’s RAD 101 Shows Promise in Detecting Brain Metastases

    New Imaging Breakthrough Targets Growing Brain Metastases Challenge Brain metastases are becoming increasingly prevalent due to improved cancer treatments extending patient survival. However, accurate detection remains a major clinical challenge. A new study highlights promising results for Radiopharm Theranostics’ (ASX:RAD, NASDAQ: RADX) novel imaging agent, RAD 101 (18F-Pivalate), in detecting brain metastases with high precision.

    Read More
    Public
  • Eureka Expands into All-Age Rental Market with Gladstone Acquisition
    • News

    Eureka Expands into All-Age Rental Market with Gladstone Acquisition

    Seizing an Opportunity in Affordable Rentals With home ownership in Australia becoming increasingly out of reach and rental demand surging, the all-age rental sector presents a significant growth opportunity. According to the most recent National Census, nearly 30% of Australians rent their homes, and 85% of these renters are under the age of 55. Eureka

    Read More
    Public
  • SportsHero Expands Indonesian Reach with XL Axiata Partnership
    • News

    SportsHero Expands Indonesian Reach with XL Axiata Partnership

    Indonesia’s gaming industry is on a rapid growth trajectory, driven by a tech-savvy, youthful population and increasing government support for esports. With over 8.3 million dedicated PC gamers, the market presents a significant opportunity for digital entertainment providers. SportsHero Limited (ASX: SHO) has now secured a key position in this expanding sector through a two-year

    Read More
    Public
  • Altair Expands Portfolio with High-Grade Copper Acquisition in Peru
    • News

    Altair Expands Portfolio with High-Grade Copper Acquisition in Peru

    Altair Minerals Limited (ASX: ALR) has announced the proposed acquisition of the Venatica Copper Project in Peru, If completed, this transaction would position the company within one of the world’s most prolific copper-producing regions. Located just 60km from Monger Gold’s (ASX:MMG) Las Bambas Mine, which is responsible for 2% of the world’s copper supply. Venatica

    Read More
    Public
  • «
  • ‹
  • 12
  • 13
  • 14
  • 15
  • 16
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.